Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-05-24

FDA Approved: LUMIZYME — Original Application (Genzyme Corporation)

View source ↗

Summary

FDA approved Lumizyme (alglucosidase alfa) through its original application by Genzyme for Pompe disease, establishing enzyme replacement therapy for this inher…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUMIZYME (ALGLUCOSIDASE ALFA)

Snippet

ORIG AP for LUMIZYME (ALGLUCOSIDASE ALFA)